|
Join the FDA Office of Women’s Health, in collaboration with the Center for Drug Evaluation and Research and Center for Tobacco Products, for a conference on Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender. This public meeting will be held on September 27 and 28, 8:30 AM – 4:00 PM, FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (Rm. 1503-A), Silver Spring, MD 20993.
This two-day scientific conference will begin with keynote speeches by FDA Commissioner Scott Gottlieb and the U.S. Surgeon General, VADM Jerome M. Adams, M.D., M.P.H. Presentations will follow from researchers, clinicians, and policy experts discussing sex and gender influences on use, misuse, and recovery.
To register to attend this special event or view the webcast, go
to https://go.usa.gov/xUk8P. Additional space for in-person attendance
has just become available.
If you have questions about the conference, please email
to OWH_OandNConf@fda.hhs.gov. |
|
.png)
No hay comentarios:
Publicar un comentario